Precision Oncology: Translating Discovery to the Clinic | EK45

Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
Date
June 21, 2021
Speaker
Ekaterina Akimova, MSc
Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR)
An unveiled Cell-Death Mechanism Exclusive to Human Cancer Cells
Date
June 21, 2021
Speaker
Malka Armon, PhD
Tel-Aviv University
The development of a personalized CAM Avatar model to predict chemotherapeutic drug sensitivity/resistance of malignant glial tumors.
Date
June 21, 2021
Speaker
Martine Charbonneau, MSc
Sherbrooke University
Precision Pathology Through Emerging Technologies: Evaluating Tumor Burden in Melanoma Sentinel Lymph Nodes by Precise Digital Cell Counting
Date
June 21, 2021
Speaker
Alessio Giubellino, MD, PhD
University of Minnesota Medical School
Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer
Date
June 21, 2021
Speaker
David Goldrich, MD
Penn State Milton S. Hershey Medical Center
The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis
Date
June 21, 2021
Speaker
Kelly Harper, PhD
Université de Sherbrooke
Clinical Feasibility and Treatment Outcomes With Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients With Advanced Cutaneous Melanoma
Date
June 21, 2021
Speaker
Robert Hawkins, PhD
Instil Bio, Inc.
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Date
June 21, 2021
Speaker
Joo S. Lee, PhD
National Cancer Institute
Application of network-based systems pharmacology in precision medicine for T-cell acute lymphoblastic leukemia
Date
June 21, 2021
Speaker
Jingjing Liu, PhD
St Jude Children's Research Hospital
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells in patients with soft tissue sarcoma
Date
June 21, 2021
Speaker
Long-Sheng Lu, MD, PhD
Taipei Medical University
ORIC-944, a Potent and Selective Allosteric PRC2 Inhibitor, Mediates Antitumor Efficacy Through Distinct Mechanisms in Two Prostate Cancer Xenograft Models
Date
June 21, 2021
Speaker
Aleksandr Pankov, PhD
ORIC Pharmaceuticals
Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials
Date
June 21, 2021
Speaker
Deborah Plana, BS
Harvard Medical School
Unraveling the Molecular Determinants of Keloid Formation and Variable Effects of Steroid Treatment using Patient Derived Keloid Fibroblasts
Date
June 21, 2021
Speaker
Yuna Son, MS
Florida State University
Autologous culture method for precision medicine
Date
June 21, 2021
Speaker
Yao Tang, PhD
University of Maryland School of Medicine
Aberrant Allelic Expressions of Imprinted Genes as Effective Biomarkers for Early Cancer Detection
Date
June 21, 2021
Speaker
Gabriel Vanrenen, Other
Lisen Imprinting Diagnostics, Inc.

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.